Literature DB >> 500712

Protease of adenovirus type 2. Subcellular localization.

A R Bhatti, J Weber.   

Abstract

The subcellular localization of the adenovirus type 2 core polypeptide specific protease activity was investigated using an in vitro assay system. The protease activity was recovered exclusively from infected cell nuclei and was insoluble, sedimenting with the membrane fraction. Endogenous activity could be demonstrated in young virions which contain precursor PVII molecules. This protease activity only became sensitive to L-1-tosylamide-2-phenylethylchloromethyl ketone- or phenylmethylsulfonyl fluoride-mediated inhibition after disruption of the virus particles by sonication, suggesting that the enzyme was internally located. The putative precursors to virus particles, referred to as top components, which do not contain a full complement of viral DNA, did not contain protease activity. The protease released from sonicated virions converted exogenous PVII substrate molecules to polypeptide VII. The noninfectious H2ts1 virus particles synthesized at the nonpermissive temperature phenotypically resemble young virions, but unlike their wild type counterparts, were devoid of protease activity. The results show that the protease enters the precursor particles concurrently with the viral chromosome and that its presence is a prerequisite for the processing and subsequent maturation of infectious adenovirions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500712

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Proteolytic processing in African swine fever virus: evidence for a new structural polyprotein, pp62.

Authors:  C Simón-Mateo; G Andrés; F Almazán; E Viñuela
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  The primary structure of human adenovirus type 12 protease.

Authors:  A Houde; J M Weber
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

4.  Codon insertion mutants of the adenovirus terminal protein.

Authors:  P I Freimuth; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Characterization of adenovirus particles made by deletion mutants lacking the fiber gene.

Authors:  B Falgout; G Ketner
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro.

Authors:  J N Fredman; J A Engler
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Activation of adenovirus-coded protease and processing of preterminal protein.

Authors:  A Webster; I R Leith; R T Hay
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Differences in sequence content of nuclear and cytoplasmic polyribosomal RNA from adenovirus-infected cells.

Authors:  N K Chatterjee; C Tuchowski; G E Eagan; T M Haley
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

9.  Immunological and chemical identification of intracellular forms of adenovirus type 2 terminal protein.

Authors:  M Green; J Symington; K H Brackmann; M A Cartas; H Thornton; L Young
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

10.  Evaluation of adenovirus capsid labeling versus transgene expression.

Authors:  Jing Li; Aiman Fatima; Svetlana Komarova; Hideyo Ugai; Priyanka Uprety; Justin C Roth; Minghui Wang; Robert A Oster; David T Curiel; Qiana L Matthews
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.